BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $129B
1-Year Return 16.6%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Quarter Return
+10.24%
1 Year Return
+16.6%
3 Year Return
+55.5%
5 Year Return
+79.05%
10 Year Return
+178.41%
AUM
$129B
AUM Growth
-$2.36B
Cap. Flow
-$18B
Cap. Flow %
-13.99%
Top 10 Hldgs %
23.27%
Holding
4,847
New
277
Increased
2,173
Reduced
1,807
Closed
200

Sector Composition

1 Technology 28.65%
2 Consumer Discretionary 9.73%
3 Financials 9.7%
4 Healthcare 9.64%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
XOS icon
4226
Xos
XOS
$20.9M
$513 ﹤0.01%
170
XYLO
4227
DELISTED
Xylo Technologies
XYLO
$508 ﹤0.01%
+100
New +$508
RDZN icon
4228
Roadzen
RDZN
$75.2M
$506 ﹤0.01%
516
-818
-61% -$802
NEUE icon
4229
NeueHealth
NEUE
$60.1M
$490 ﹤0.01%
71
INVE icon
4230
Identive
INVE
$85.9M
$489 ﹤0.01%
150
+12
+9% +$39
CUE icon
4231
Cue Biopharma
CUE
$57M
$488 ﹤0.01%
715
VATE icon
4232
INNOVATE Corp
VATE
$67.3M
$479 ﹤0.01%
93
KALA icon
4233
KALA BIO
KALA
$131M
$466 ﹤0.01%
98
API
4234
Agora
API
$343M
$446 ﹤0.01%
117
KZR icon
4235
Kezar Life Sciences
KZR
$28.9M
$440 ﹤0.01%
96
TELA icon
4236
TELA Bio
TELA
$62.6M
$435 ﹤0.01%
224
ATHA icon
4237
Athira Pharma
ATHA
$14.2M
$422 ﹤0.01%
1,399
+38
+3% +$11
IMA
4238
ImageneBio, Inc. Common Stock
IMA
$102M
$422 ﹤0.01%
26
SENS icon
4239
Senseonics Holdings
SENS
$375M
$416 ﹤0.01%
874
+1
+0.1%
SOND icon
4240
Sonder
SOND
$22.9M
$413 ﹤0.01%
153
+6
+4% +$16
WDH
4241
Waterdrop
WDH
$669M
$405 ﹤0.01%
+300
New +$405
UPLD icon
4242
Upland Software
UPLD
$71.6M
$400 ﹤0.01%
205
+16
+8% +$31
ATRA icon
4243
Atara Biotherapeutics
ATRA
$85.1M
$386 ﹤0.01%
50
MAXN icon
4244
Maxeon Solar Technologies
MAXN
$65M
$383 ﹤0.01%
125
MPTI.WS
4245
M-tron Industries, Inc. Warrants to Purchase Shares of Common Stock, Expiring on or before April 25, 2028
MPTI.WS
$5.21M
$382 ﹤0.01%
+369
New +$382
KLRS
4246
Kalaris Therapeutics, Inc. Common Stock
KLRS
$72.8M
$376 ﹤0.01%
141
+14
+11% +$37
ARQQ icon
4247
Arqit Quantum
ARQQ
$513M
$370 ﹤0.01%
10
-1,051
-99% -$38.9K
GSLC icon
4248
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.5B
$364 ﹤0.01%
+3
New +$364
IJK icon
4249
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.2B
$364 ﹤0.01%
4
-100,296
-100% -$9.13M
PHG icon
4250
Philips
PHG
$26.8B
$360 ﹤0.01%
15
-1
-6% -$24